These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 27372386)

  • 21. Stage III thymoma: pattern of failure after surgery and postoperative radiotherapy and its implication for future study.
    Myojin M; Choi NC; Wright CD; Wain JC; Harris N; Hug EB; Mathisen DJ; Lynch T; Carey RW; Grossbard M; Finkelstein DM; Grillo HC
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):927-33. PubMed ID: 10705015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiotherapy and chemotherapy for invasive thymomas: a multicentric retrospective review of 90 cases. The FNCLCC trialists. Fédération Nationale des Centres de Lutte Contre le Cancer.
    Mornex F; Resbeut M; Richaud P; Jung GM; Mirabel X; Marchal C; Lagrange JL; Rambert P; Chaplain G; Nguyen TD
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):651-9. PubMed ID: 7790251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intensity Modulated Radiation Therapy for Pleural Recurrence of Thymoma: A Prospective Phase 2 Study.
    Wang CL; Gao LT; Lyu CX; Wang JM; Liu J; Gu HL; Liu Y; Fu XL
    Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):775-782. PubMed ID: 33039590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of stages I-II thymoma treated by complete resection with or without adjuvant radiation.
    Singhal S; Shrager JB; Rosenthal DI; LiVolsi VA; Kaiser LR
    Ann Thorac Surg; 2003 Nov; 76(5):1635-41; discussion 1641-2. PubMed ID: 14602300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant radiotherapy for thymic epithelial tumor: treatment results and prognostic factors.
    Kundel Y; Yellin A; Popovtzer A; Pfeffer R; Symon Z; Simansky DA; Oberman B; Sadezki S; Brenner B; Catane R; Levitt ML
    Am J Clin Oncol; 2007 Aug; 30(4):389-94. PubMed ID: 17762439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spot scanning proton therapy for malignancies of the base of skull: treatment planning, acute toxicities, and preliminary clinical outcomes.
    Grosshans DR; Zhu XR; Melancon A; Allen PK; Poenisch F; Palmer M; McAleer MF; McGovern SL; Gillin M; DeMonte F; Chang EL; Brown PD; Mahajan A
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):540-6. PubMed ID: 25304948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pencil-beam scanning proton therapy for anal cancer: a dosimetric comparison with intensity-modulated radiotherapy.
    Ojerholm E; Kirk ML; Thompson RF; Zhai H; Metz JM; Both S; Ben-Josef E; Plastaras JP
    Acta Oncol; 2015; 54(8):1209-17. PubMed ID: 25734796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of postoperative radiation therapy for completely resected stage III thymoma and effect of higher heart radiation dose on risk of cardiovascular disease: A retrospective cohort study.
    Liao J; Liu T; Zhang H; Cai F; Chen J; Dang J
    Int J Surg; 2018 May; 53():345-349. PubMed ID: 29673690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postoperative radiotherapy for completely resected stage II or III thymoma.
    Chang JH; Kim HJ; Wu HG; Kim JH; Kim YT
    J Thorac Oncol; 2011 Jul; 6(7):1282-6. PubMed ID: 21642871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early toxicity in patients treated with postoperative proton therapy for locally advanced breast cancer.
    Cuaron JJ; Chon B; Tsai H; Goenka A; DeBlois D; Ho A; Powell S; Hug E; Cahlon O
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):284-91. PubMed ID: 25754632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of adjuvant radiotherapy for stage II thymoma after complete tumor resection.
    Chen YD; Feng QF; Lu HZ; Mao YS; Zhou ZM; Ou GF; Wang M; Zhao J; Zhang HX; Xiao ZF; Chen DF; Liang J; Zhai YR; Wang LH; He J
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1400-6. PubMed ID: 20378264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.
    Chera BS; Rodriguez C; Morris CG; Louis D; Yeung D; Li Z; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1173-80. PubMed ID: 19386423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proton Beam Therapy for Locally Advanced Head and Neck Tumors: An Analysis of Dosimetric and Clinical Outcomes.
    Sheikh S; Kharouta MZ; Pidikiti R; Damico NJ; Choi S; Dorth JA; Mansur DB; Machtay MX; Yao M; Bhatt AD
    Am J Clin Oncol; 2022 Feb; 45(2):81-87. PubMed ID: 35073281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proton radiotherapy for pediatric bladder/prostate rhabdomyosarcoma: clinical outcomes and dosimetry compared to intensity-modulated radiation therapy.
    Cotter SE; Herrup DA; Friedmann A; Macdonald SM; Pieretti RV; Robinson G; Adams J; Tarbell NJ; Yock TI
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1367-73. PubMed ID: 20934266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiotherapy for invasive thymoma and thymic carcinoma. Clinicopathological review.
    Mayer R; Beham-Schmid C; Groell R; Smolle-Juettner FM; Quehenberger F; Stuecklschweiger GF; Prettenhofer U; Stranzl H; Renner H; Hackl A
    Strahlenther Onkol; 1999 Jun; 175(6):271-8. PubMed ID: 10392168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of adjuvant radiation therapy for resected stage III thymoma: a population-based study.
    Weksler B; Shende M; Nason KS; Gallagher A; Ferson PF; Pennathur A
    Ann Thorac Surg; 2012 Jun; 93(6):1822-8; discussion 1828-9. PubMed ID: 22551847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant Radiotherapy for Stages II and III Resected Thymoma: A Single-institutional Experience.
    Yan J; Liu Q; Moseley JN; Baik CS; Chow LQ; Goulart BH; Zlotnick D; Papanicolau-Sengos A; Gallaher I; Knopp JM; Zeng J; Patel S
    Am J Clin Oncol; 2016 Jun; 39(3):223-7. PubMed ID: 24517958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Volumetric modulated arc therapy versus intensity-modulated proton therapy in the postoperative irradiation of thymoma.
    Franceschini D; Cozzi L; Loi M; Franzese C; Reggiori G; Mancosu P; Clivio A; Fogliata A; Scorsetti M
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2267-2276. PubMed ID: 32514629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consolidative mediastinal irradiation of malignant lymphoma using active scanning proton beams: clinical outcome and dosimetric comparison.
    König L; Bougatf N; Hörner-Rieber J; Chaudhri N; Mielke T; Klüter S; Haefner MF; Rieken S; Haberer T; Debus J; Herfarth K
    Strahlenther Onkol; 2019 Jul; 195(7):677-687. PubMed ID: 30972453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of organ dose reduction and secondary cancer risk associated with the use of proton beam therapy and intensity modulated radiation therapy in treatment of neuroblastomas.
    Fuji H; Schneider U; Ishida Y; Konno M; Yamashita H; Kase Y; Murayama S; Onoe T; Ogawa H; Harada H; Asakura H; Nishimura T
    Radiat Oncol; 2013 Nov; 8():255. PubMed ID: 24180282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.